GB

Geoffrey Brooke

Cynata Therapeutics Limited | Non-Executive Director, Non-Executive Chairman
Dr Brooke has served as a Director of Saluda Medical Pty Limited and subsequently the Company since October 2020. Since 2020, he has served as Senior Partner of BioScience Managers Pty Limited, an international healthcare investment firm. He has over 30 years of healthcare venture capital management and investment experience. He has also served as director of Cynata Therapeutics Ltd (ASX:CYP) since May 2019, where he currently serves as the non executive chair of the board, Actinogen Medical Ltd (ASX:ACW) since March 2017, where he currently serves as non executive chair of the board, and Acrux Ltd (ASX:ACR) since June 2016.

Companies and Roles

Company
Title
Tenure
Since
CYP
CYP
Cynata Therapeutics Limited
  • Non-Executive Director
  • Non-Executive Chairman
7yrs, 4mthMay 2019
ACW
ACW
Actinogen Medical Limited
  • Non-Executive Chairman
  • Non-Executive Director
5yrs, 8mthFeb 2021
SLD
SLD
Saluda Medical, Inc.
  • Non-Executive Director
5yrs, 11mthOct 2020
ACR
ACR
Acrux Limited
  • Non-Executive Director
10yrs, 4mthJun 2016

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
ACR
ACR
Acrux Limited
14/09/267,805,733679,935285,714N/A
ACW
ACW
Actinogen Medical Limited
09/09/2633,329,3706,062,9191,839,233N/A
CYP
CYP
Cynata Therapeutics Limited
29/11/25N/A312,898500,000N/A
SLD
SLD
Saluda Medical, Inc.
20/10/20N/AN/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ACR
ACR
Acrux Limited
14/09/26
Exercise
4,109,653$0.011$45,206Conversion of securities
ACR
ACR
Acrux Limited
14/09/26
Buy
4,109,653$0.011$45,206Conversion of securities
ACW
ACW
Actinogen Medical Limited
09/09/26
Buy
237,029$0.037$8,888Exercise of options
ACW
ACW
Actinogen Medical Limited
09/09/26
Exercise
237,029$0.037$8,888Exercise of options
ACR
ACR
Acrux Limited
03/09/26
Issued
2,400,000$0.011$26,400Issue of securities